Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization

Cannabinoids

Home » Health and medicine » Cannabinoids

Octarine Bio IVS Receives Funding from Vækstfonden to Develop Biosynthetic Platform for Cannabinoid and Psychedelic Tryptamine Derivatives

Octarine Bio IVS, a synthetic biology company developing functionally superior cannabinoid and psychedelic tryptamine derivatives has received funding from Danish State’s investment fund, Vækstfonden. COPENHAGEN...

Lygos Acquires Librede to Accelerate Cannabinoid Production for Consumer, Nutraceutical and Pharmaceutical Products

European synthetic biology company Octarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives

With investors including Oskare Capital and Canopy Growth Cooperation founder Bruce Linton January 10, 2020 05:00 AM Eastern Standard Time COPENHAGEN, Denmark–(BUSINESS WIRE)–Today, Octarine Bio IVS...